AFP and neoplasm: The results showed that compared with other preparations, MPDA@SPIO/SA-PEI/AFP-Fth had better ability to enhance MRI contrast of T2-weighted images in tumor region, and could be used as an effective MRI contrast agent for early detection of hepatocellular carcinoma (HCC).